BioCentury
ARTICLE | Financial News

Neurana closes $60M series A

May 7, 2018 9:46 PM UTC

Neurana Pharmaceuticals Inc. (San Diego, Calif.) closed a $60 million series A round led by Sofinnova Ventures. Also participating were New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital Management and MagnaSci Ventures.

Neurana has rights in North America to small molecule muscle relaxer tolperisone from Sanochemia Pharmazeutika AG (Xetra:SAC). The drug is marketed in Europe and Asia...